Download
1 / 3
30 likes | 112 Views
The global soft tissue repair market is expected to reach $14.7 billion in 2019 from $10.3 billion in 2014, at a CAGR of 7.5% during the forecast period of 2014 to 2019. Market growth will be attributed to innovative new product launches, the rising demand for treatment from the aging population, increasing healthcare expenditure, and the lack of substitutes.<br><br>The soft tissue repair market studied in this report is mainly segmented by products and applications. The market, by products, is segmented into tissue patch/mesh, soft tissue fixation devices, and laparoscopic instruments. On the basis of application the market is segmented into hernia repair, dural repair, vaginal sling procedure, skin repair, orthopedic repair, dental repair, and breast reconstruction repair.<br><br>Developed geographies like North America and Europe are saturated markets and expected to grow at a slower rate, whereas the Asian market is expected to witness the highest growth due to the increasing number of soft tissue repair surgical procedures (which is caused by the rising aging population and huge patient base).<br><br>The key players operating in this market are LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex, Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.).
E N D
Soft Tissue Repair Market worth $14.7 Billion in 2019 The report “Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019”analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World. https://www.marketsandmarkets.com/Market-Reports/soft-tissue-repair-devices-market-216009453.html
Summary • This report studies the global soft tissue repair market, with forecast to 2019. The soft tissue repair market is expected to reach $14.7 billion in 2019 from $10.3 billion in 2014, at a healthy CAGR of 7.5% from 2014 to 2019. Growth in this market is attributed to the increasing incidence of soft tissue injuries, increasing healthcare expenditure, lack of substitutes for soft tissue repair surgery, increasing aging population & obesity rate, and geographic expansion by leading players in emerging markets. However, the increasing cost of surgical procedures, the lack of reimbursement, and stringent regulatory requirements are curbing market growth to a certain extent. • The global soft tissue repair market is segmented by product, application, and region. This report also discusses key market drivers, restraints, opportunities, and challenges for this market and submarkets. The market, by products, is segmented into tissue patches/meshes, soft tissue fixation devices, and laparoscopic instruments. • North America, a major market for global soft tissue repair, occupied a major share in this market, closely followed by Europe. However, emerging countries in the Asia-Pacific region and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. Countries like India, China, and Brazil will majorly drive market growth owing to rising investments by public and private players to provide improved healthcare services in these countries, the presence of a large patient population, and the focus of leading players on capturing growth opportunities in these markets. • Key players in this market include LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.). https://www.marketsandmarkets.com/Market-Reports/soft-tissue-repair-devices-market-216009453.html
About MarketsandMarkets • About MarketsandMarkets • MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. • M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. • We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. • Contact:Mr. RohanNorth - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252Tel: +1-888-600-6441Email: sales@marketsandmarkets.com
